Activated charcoal in organophosphate poisoning
Activated charcoal is reasonable only if given early (ideally within 1 hour, consider up to 2–4 hours if large ingestion and GI motility intact) at a single dose of 1 g/kg (adult max 50–100 g), and it is contraindicated if the airway is unprotected or bowel obstruction is suspected. 1, 2
Indication (time- and risk-based)
- Give single-dose activated charcoal (SDAC) when:
- Potentially toxic oral organophosphate ingestion AND presentation within 1 hour. This timing offers the greatest absorption reduction and the only plausible chance to affect outcomes tied to morbidity/mortality/QOL, despite no proven clinical outcome benefit in trials 1, 2.
- Consider SDAC up to 2–4 hours post-ingestion if:
- Not routine beyond 4 hours, given rapidly declining efficacy and lack of outcome benefit data. Prioritize proven mortality/morbidity interventions (airway/ventilation, atropine, pralidoxime) 1, 2, 3.
- Give single-dose activated charcoal (SDAC) when:
Dose and administration
- Adults: 50–100 g orally/NG as a single dose (or 1 g/kg if weight-based). Children: 1 g/kg (typical max 50 g) 4, 1, 2.
- Avoid cathartics (e.g., sorbitol), especially in children, due to risks of dehydration/electrolyte derangements and no outcome benefit; repeated charcoal with sorbitol has caused fatal hypernatremic dehydration 4, 5.
- Multidose activated charcoal is not indicated for organophosphates (no evidence of improved morbidity/mortality; reserve for specific agents like carbamazepine, theophylline, etc.) 5.
Contraindications and caveats
- Absolute: Unprotected or absent airway reflexes (unless intubated), risk of aspiration; suspected/known GI obstruction or perforation 1, 2, 5.
- Relative: Intractable vomiting, hemodynamic instability precluding safe administration; co-ingestants not adsorbed by charcoal (not typical for OPs) 4, 1.
- Do not delay antidotes or airway interventions to give charcoal. Mortality benefit comes from prompt atropine, pralidoxime, and ventilatory support; charcoal has no proven outcome benefit in OP poisoning and must not interfere with definitive therapy 3, 1, 6.
Evidence nuance (why this recommendation)
- Highest-quality consensus statements on SDAC show no demonstrated improvement in clinical outcomes; benefit is time-dependent and greatest within 1 hour, with uncertain benefit thereafter 1, 2.
- An OP-specific retrospective study found no improvement in mortality, respiratory failure, or ventilation duration with charcoal-sorbitol vs no charcoal, reinforcing that charcoal must never delay life-saving therapies 6.
- Current poisoning guidelines emphasize antidotal therapy (atropine, oximes) for organophosphates; use charcoal only as early adjunct decontamination when safe 3.
Practical algorithm
- If suspected OP ingestion:
- Secure airway/oxygenation; intubate if needed.
- Start atropine immediately; add pralidoxime per dosing guidance 3.
- Consider SDAC 1 g/kg (max 50–100 g) if:
- Ingestion ≤1 hour (strongest rationale), or up to 2–4 hours if large ingestion/slow GI transit,
- Airway is intact or protected,
- No bowel obstruction/perforation.
- Avoid sorbitol and multidose charcoal.
- Monitor for aspiration; stop if vomiting or deterioration.
- If suspected OP ingestion:
Common pitfalls to avoid
- Giving charcoal before securing a compromised airway → aspiration pneumonia and worse outcomes 1, 2.
- Delaying atropine/oximes or ventilation to administer charcoal → increases mortality 3.
- Routine use beyond 1 hour without clear rationale, or using multidose regimens in OP poisoning → no proven benefit, added risk 1, 2, 5.